Data:
{
"symbol": "NUVB",
"price": 6.845,
"marketCap": 2376597491,
"beta": 1.525,
"lastDividend": 0,
"range": "2.871-9.75",
"change": -0.15,
"changePercentage": -2.14439,
"volume": 1038415,
"averageVolume": 6085532,
"companyName": "Nuvation Bio Inc.",
"currency": "USD",
"cik": "0001811063",
"isin": "US67080N1019",
"cusip": "67080N101",
"exchangeFullName": "New York Stock Exchange",
"exchange": "NYSE",
"industry": "Biotechnology",
"website": "https://www.nuvationbio.com",
"description": "Nuvation Bio Inc. functions as a clinical-stage biopharmaceutical enterprise committed to discovering and advancing therapeutic solutions for oncological conditions. Its foremost experimental compound, NUV-422, is a small molecule designed to inhibit cyclin-dependent kinases (CDK)2, CDK4, and CDK6. The company's development pipeline further encompasses NUV-868, an orally administered, selective small molecule BET inhibitor that epigenetically influences proteins critical for tumor proliferation and cellular differentiation; NUV-569, a unique oral small molecule targeting the Wee1 kinase to facilitate DNA damage repair; and NUV-1182, an antagonist of adenosine receptors. Additionally, Nuvation Bio is progressing a sophisticated drug-drug conjugate (DDC) platform, engineered to deliver a poly ADP ribose polymerase (PARP) inhibitor in conjunction with existing anti-cancer warheads, particularly for the treatment of ER-positive breast and ovarian cancers. Established in 2018, the firm was initially named RePharmation Inc. before rebranding as Nuvation Bio Inc. in April 2019, and its central operations are based in New York, New York.",
"ceo": "David T. Hung",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "305",
"phone": "332 208 6102",
"address": "1500 Broadway",
"city": "New York City",
"state": "NY",
"zip": "10036",
"image": "https://images.financialmodelingprep.com/symbol/NUVB.png",
"ipoDate": "2020-08-26",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "NUVB",
"name": "Nuvation Bio Inc.",
"price": 6.845,
"changePercentage": -2.14439,
"change": -0.15,
"volume": 1038415,
"dayLow": 6.735,
"dayHigh": 6.9956,
"yearHigh": 9.75,
"yearLow": 2.871,
"marketCap": 2376597491,
"priceAvg50": 6.2374,
"priceAvg200": 5.8973,
"exchange": "NYSE",
"open": 6.96,
"previousClose": 6.995,
"timestamp": 1787930326,
"chart_vwap_daily": [
{
"t": "2026-07-20",
"v": 6.3129,
"c": 6.26
},
{
"t": "2026-07-21",
"v": 6.4408,
"c": 6.43
},
{
"t": "2026-07-22",
"v": 6.3173,
"c": 6.55
},
{
"t": "2026-07-23",
"v": 6.4692,
"c": 6.49
},
{
"t": "2026-07-24",
"v": 6.4459,
"c": 6.42
},
{
"t": "2026-07-27",
"v": 6.649,
"c": 6.66
},
{
"t": "2026-07-28",
"v": 6.5872,
"c": 6.69
},
{
"t": "2026-07-29",
"v": 6.5645,
"c": 6.59
},
{
"t": "2026-07-30",
"v": 6.6308,
"c": 6.7
},
{
"t": "2026-07-31",
"v": 6.3751,
"c": 6.33
},
{
"t": "2026-08-03",
"v": 6.2527,
"c": 6.16
},
{
"t": "2026-08-04",
"v": 6.428,
"c": 6.44
},
{
"t": "2026-08-05",
"v": 6.4248,
"c": 6.37
},
{
"t": "2026-08-06",
"v": 6.2716,
"c": 6.11
},
{
"t": "2026-08-07",
"v": 6.5051,
"c": 6.6
},
{
"t": "2026-08-10",
"v": 6.5261,
"c": 6.6
},
{
"t": "2026-08-11",
"v": 6.4729,
"c": 6.37
},
{
"t": "2026-08-12",
"v": 6.3964,
"c": 6.42
},
{
"t": "2026-08-13",
"v": 6.2042,
"c": 6.1
},
{
"t": "2026-08-14",
"v": 6.1082,
"c": 6.22
},
{
"t": "2026-08-17",
"v": 6.4557,
"c": 6.48
},
{
"t": "2026-08-18",
"v": 6.7444,
"c": 6.96
},
{
"t": "2026-08-19",
"v": 7.3317,
"c": 7.26
},
{
"t": "2026-08-20",
"v": 6.9253,
"c": 6.83
},
{
"t": "2026-08-21",
"v": 6.9869,
"c": 6.93
},
{
"t": "2026-08-24",
"v": 6.7801,
"c": 6.76
},
{
"t": "2026-08-25",
"v": 7.0094,
"c": 7.1
},
{
"t": "2026-08-26",
"v": 6.998,
"c": 6.96
},
{
"t": "2026-08-27",
"v": 7.0248,
"c": 6.99
},
{
"t": "2026-08-28",
"v": 6.819,
"c": 6.85
}
],
"vwap_summary": {
"days": 30,
"days_above": 15,
"days_below": 15,
"pct_days_above": 50,
"position": "above",
"gap_pct": 0.45,
"streak_days": 1
}
}
Data:
{
"volume": 1038415,
"avgVolume": 6085532,
"short_ratio": [
{
"symbol": "NUVB",
"file_date": "2026-08-27",
"date": "20260827",
"short_volume": 979951,
"short_exempt_volume": 11351,
"total_volume": 1556889,
"short_volume_ratio": 0.6294,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 6.47,
"vah": 6.89,
"val": 5.92,
"profile": [
{
"price": 5.91,
"volume": 139462
},
{
"price": 5.94,
"volume": 222863
},
{
"price": 5.96,
"volume": 553291
},
{
"price": 5.99,
"volume": 400731
},
{
"price": 6.02,
"volume": 3946534
},
{
"price": 6.04,
"volume": 469086
},
{
"price": 6.07,
"volume": 878651
},
{
"price": 6.1,
"volume": 1560767
},
{
"price": 6.12,
"volume": 911930
},
{
"price": 6.15,
"volume": 2302933
},
{
"price": 6.18,
"volume": 2179852
},
{
"price": 6.21,
"volume": 1233682
},
{
"price": 6.23,
"volume": 2976839
},
{
"price": 6.26,
"volume": 2787811
},
{
"price": 6.29,
"volume": 2251409
},
{
"price": 6.31,
"volume": 1556000
},
{
"price": 6.34,
"volume": 2008967
},
{
"price": 6.37,
"volume": 3333926
},
{
"price": 6.39,
"volume": 4044719
},
{
"price": 6.42,
"volume": 2825096
},
{
"price": 6.45,
"volume": 2438946
},
{
"price": 6.47,
"volume": 4899742
},
{
"price": 6.5,
"volume": 4184451
},
{
"price": 6.53,
"volume": 2572004
},
{
"price": 6.56,
"volume": 2551260
},
{
"price": 6.58,
"volume": 4024660
},
{
"price": 6.61,
"volume": 423373
},
{
"price": 6.64,
"volume": 427439
},
{
"price": 6.66,
"volume": 144067
},
{
"price": 6.69,
"volume": 538728
},
{
"price": 6.72,
"volume": 986682
},
{
"price": 6.74,
"volume": 1443512
},
{
"price": 6.77,
"volume": 1412308
},
{
"price": 6.8,
"volume": 923122
},
{
"price": 6.83,
"volume": 1365037
},
{
"price": 6.85,
"volume": 1351465
},
{
"price": 6.88,
"volume": 1602884
},
{
"price": 6.91,
"volume": 1717644
},
{
"price": 6.93,
"volume": 3102714
},
{
"price": 6.96,
"volume": 1756303
},
{
"price": 6.99,
"volume": 2444762
},
{
"price": 7.01,
"volume": 2196884
},
{
"price": 7.04,
"volume": 2357995
},
{
"price": 7.07,
"volume": 1645072
},
{
"price": 7.1,
"volume": 2146227
},
{
"price": 7.12,
"volume": 569122
},
{
"price": 7.15,
"volume": 303872
},
{
"price": 7.18,
"volume": 118206
},
{
"price": 7.2,
"volume": 170385
},
{
"price": 7.23,
"volume": 1021623
},
{
"price": 7.26,
"volume": 1184242
},
{
"price": 7.28,
"volume": 521818
},
{
"price": 7.31,
"volume": 1665337
},
{
"price": 7.34,
"volume": 630134
},
{
"price": 7.36,
"volume": 1774758
},
{
"price": 7.39,
"volume": 45867
},
{
"price": 7.42,
"volume": 662753
},
{
"price": 7.45,
"volume": 235402
},
{
"price": 7.47,
"volume": 1649330
},
{
"price": 7.5,
"volume": 458266
}
],
"sessions": 20
}
}
Data:
{
"symbol": "NUVB",
"marketCap": 2376597491,
"enterpriseValueTTM": 2370135491,
"evToSalesTTM": 13.950179464390818,
"evToOperatingCashFlowTTM": -28.686493803103293,
"evToFreeCashFlowTTM": -28.651469252807562,
"evToEBITDATTM": -18.656461229052038,
"netDebtToEBITDATTM": 0.050865468628238125,
"currentRatioTTM": 8.373373292605613,
"incomeQualityTTM": -0.7360993558618355,
"grahamNumberTTM": null,
"grahamNetNetTTM": 0.5850646557903489,
"taxBurdenTTM": 1,
"interestBurdenTTM": 1.1597773752573808,
"workingCapitalTTM": 639677000,
"investedCapitalTTM": 653924000,
"returnOnAssetsTTM": -0.20124432003631954,
"operatingReturnOnAssetsTTM": -0.20317639347360092,
"returnOnTangibleAssetsTTM": -0.204065316373631,
"returnOnEquityTTM": -0.4973403063502364,
"returnOnInvestedCapitalTTM": -0.20684565856473827,
"returnOnCapitalEmployedTTM": -0.2092381884855598,
"earningsYieldTTM": -0.06275921603067426,
"freeCashFlowYieldTTM": -0.0348073244683906,
"capexToOperatingCashFlowTTM": -0.0012224347026215778,
"capexToDepreciationTTM": -0.15165165165165165,
"capexToRevenueTTM": 0.000594467333725721,
"salesGeneralAndAdministrativeToRevenueTTM": 0.933402001177163,
"researchAndDevelopementToRevenueTTM": 0.758393172454385,
"stockBasedCompensationToRevenueTTM": -0.1170394349617422,
"intangiblesToTotalAssetsTTM": 0.013823987277418627,
"averageReceivablesTTM": 28849000,
"averagePayablesTTM": 17262000,
"averageInventoryTTM": 17872500,
"daysOfSalesOutstandingTTM": 68.13190111830488,
"daysOfPayablesOutstandingTTM": 428.4381978832896,
"daysOfInventoryOutstandingTTM": 705.2980871929313,
"operatingCycleTTM": 773.4299883112362,
"cashConversionCycleTTM": 344.9917904279466,
"freeCashFlowToEquityTTM": -97956000,
"freeCashFlowToFirmTTM": -55997000,
"tangibleAssetValueTTM": 243572000,
"netCurrentAssetValueTTM": 235793000,
"grossProfitMarginTTM": 0.9393819894055326,
"ebitMarginTTM": -0.760364920541495,
"ebitdaMarginTTM": -0.7477398469688051,
"operatingProfitMarginTTM": -0.8100412007062978,
"pretaxProfitMarginTTM": -0.881854031783402,
"continuousOperationsProfitMarginTTM": -0.881854031783402,
"netProfitMarginTTM": -0.881854031783402,
"bottomLineProfitMarginTTM": -0.881854031783402,
"receivablesTurnoverTTM": 5.357255470770007,
"payablesTurnoverTTM": 0.8519315079824634,
"inventoryTurnoverTTM": 0.5175116828300086,
"fixedAssetTurnoverTTM": 42.958280657395704,
"assetTurnoverTTM": 0.2282059306678415,
"quickRatioTTM": 8.143980174053368,
"solvencyRatioTTM": -0.30099930906430183,
"cashRatioTTM": 2.980854129444989,
"priceToEarningsRatioTTM": -15.75373993095512,
"priceToEarningsGrowthRatioTTM": -0.48182393963164544,
"forwardPriceToEarningsGrowthRatioTTM": 0.31121135287822843,
"priceToEarningsDilutedRatioTTM": -15.710351159054396,
"priceToEarningsDilutedGrowthRatioTTM": -0.5056580433354033,
"priceToBookRatioTTM": 9.40397476601645,
"priceToSalesRatioTTM": 13.988213602118893,
"priceToFreeCashFlowRatioTTM": -28.729585375288615,
"priceToOperatingCashFlowRatioTTM": -28.894612209823045,
"debtToAssetsRatioTTM": 0.3386715701615709,
"debtToEquityRatioTTM": 0.9932168405130306,
"debtToCapitalRatioTTM": 0.4982984391489429,
"longTermDebtToCapitalRatioTTM": 0.49064001059394297,
"financialLeverageRatioTTM": 2.9326844294582926,
"workingCapitalTurnoverRatioTTM": 0.2950462105924889,
"operatingCashFlowRatioTTM": -0.9523600945190479,
"operatingCashFlowSalesRatioTTM": -0.4862978222483814,
"freeCashFlowOperatingCashFlowRatioTTM": 1.0012224347026215,
"debtServiceCoverageRatioTTM": -3.900911966100654,
"interestCoverageRatioTTM": -5.159556122066432,
"shortTermOperatingCashFlowCoverageRatioTTM": -14.020363142711691,
"operatingCashFlowCoverageRatioTTM": -0.32768043404113556,
"capitalExpenditureCoverageRatioTTM": -818.039603960396,
"dividendPaidAndCapexCoverageRatioTTM": -818.039603960396,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0.48714052240731714,
"netIncomePerShareTTM": -0.4295868337299653,
"interestDebtPerShareTTM": 0.7994265561831579,
"cashPerShareTTM": 1.8951056570232532,
"bookValuePerShareTTM": 0.7278837055939444,
"tangibleBookValuePerShareTTM": 0.6983742867792528,
"shareholdersEquityPerShareTTM": 0.7278837055939444,
"operatingCashFlowPerShareTTM": -0.23689537517561718,
"capexPerShareTTM": 0.0002895891275052327,
"freeCashFlowPerShareTTM": -0.23718496430312241,
"netIncomePerEBTTTM": 1,
"ebtPerEbitTTM": 1.0886533067879616,
"priceToFairValueTTM": 9.40397476601645,
"debtToMarketCapTTM": 0.10537207118510755,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": -18.656461229052038,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 62902000
}
],
"dcf": {
"symbol": "NUVB",
"date": "2026-08-28",
"dcf": 3.432862014787144,
"Stock Price": 6.99
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "NUVB",
"reportedCurrency": "USD",
"cik": "0001811063",
"filingDate": "2026-03-02",
"acceptedDate": "2026-03-02 16:49:05",
"fiscalYear": "2025",
"period": "FY",
"revenue": 62902000,
"costOfRevenue": 8442000,
"grossProfit": 54460000,
"researchAndDevelopmentExpenses": 115106000,
"generalAndAdministrativeExpenses": 0,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 151562000,
"otherExpenses": 856000,
"operatingExpenses": 267524000,
"costAndExpenses": 275966000,
"netInterestIncome": 7748000,
"interestIncome": 21430000,
"interestExpense": 13682000,
"depreciationAndAmortization": 1739000,
"ebitda": -189206000,
"ebit": -190945000,
"nonOperatingIncomeExcludingInterest": -22119000,
"operatingIncome": -213064000,
"totalOtherIncomeExpensesNet": 8437000,
"incomeBeforeTax": -204627000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": -204627000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -204627000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -204627000,
"eps": -0.6,
"epsDiluted": -0.6,
"weightedAverageShsOut": 341541000,
"weightedAverageShsOutDil": 341541000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "NUVB",
"reportedCurrency": "USD",
"cik": "0001811063",
"filingDate": "2026-03-02",
"acceptedDate": "2026-03-02 16:49:05",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 164086000,
"shortTermInvestments": 365125000,
"cashAndShortTermInvestments": 529211000,
"netReceivables": 19361000,
"accountsReceivables": 19361000,
"otherReceivables": 0,
"inventory": 11411000,
"prepaids": 0,
"otherCurrentAssets": 11536000,
"totalCurrentAssets": 571519000,
"propertyPlantEquipmentNet": 4482000,
"goodwill": 0,
"intangibleAssets": 11214000,
"goodwillAndIntangibleAssets": 11214000,
"longTermInvestments": 0,
"taxAssets": 0,
"otherNonCurrentAssets": 7607000,
"totalNonCurrentAssets": 23303000,
"otherAssets": 0,
"totalAssets": 594822000,
"totalPayables": 9479000,
"accountPayables": 9479000,
"otherPayables": 0,
"accruedExpenses": 0,
"shortTermDebt": 7604000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 65148000,
"totalCurrentLiabilities": 82231000,
"longTermDebt": 2543000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 145819000,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 58513000,
"totalNonCurrentLiabilities": 206875000,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 289106000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 1421273000,
"retainedEarnings": -1115370000,
"additionalPaidInCapital": 0,
"accumulatedOtherComprehensiveIncomeLoss": -187000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 305716000,
"totalEquity": 305716000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 594822000,
"totalInvestments": 365125000,
"totalDebt": 10147000,
"netDebt": -153939000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "NUVB",
"reportedCurrency": "USD",
"cik": "0001811063",
"filingDate": "2026-03-02",
"acceptedDate": "2026-03-02 16:49:05",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -204627000,
"depreciationAndAmortization": 1739000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 35894000,
"changeInWorkingCapital": -11979000,
"accountsReceivables": -3069000,
"inventory": -11411000,
"accountsPayables": 3131000,
"otherWorkingCapital": -630000,
"otherNonCashItems": 5546000,
"netCashProvidedByOperatingActivities": -173427000,
"investmentsInPropertyPlantAndEquipment": -8353999,
"acquisitionsNet": 0,
"purchasesOfInvestments": -354416000,
"salesMaturitiesOfInvestments": 462290000,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": 99520000,
"netDebtIssuance": 191114000,
"longTermNetDebtIssuance": 191114000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 11421000,
"netCommonStockIssuance": 11421000,
"commonStockIssuance": 11421000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": 202535000,
"effectOfForexChangesOnCash": -265000,
"netChangeInCash": 128363000,
"cashAtEndOfPeriod": 164086000,
"cashAtBeginningOfPeriod": 35723000,
"operatingCashFlow": -173427000,
"capitalExpenditure": -354000,
"freeCashFlow": -173781000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 6.845,
"rsi": 54.986863224190024,
"sma20": 6.625250000000003,
"sma50": 6.267699999999999,
"sma200": 5.908325000000001,
"adx": 17.52386366121093,
"atr": 0.36,
"atr_pct": 5.26,
"atr_expansion_pct": 1.8,
"di_plus": 29.9,
"di_minus": 21.9,
"high_52w": 9.54,
"low_52w": 2.69,
"structure": {
"ema8": 6.878453267246386,
"ema21": 6.67305305921426,
"ema50": 6.261881037559676,
"ema200": 5.416600526006709,
"ema10": 6.846884221207899,
"ema20": 6.6885442565442,
"ema10_slope_pct": 2.15,
"ema20_slope_pct": 2.42,
"trend_dir": "up",
"checks": {
"price_above_all": false,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": 2.6,
"_no_bars": false,
"macd": {
"macd": 0.218,
"signal": 0.214,
"histogram": 0.004
},
"bollinger": {
"mid": 6.63,
"upper": 7.31,
"lower": 5.94,
"width_pct": 20.64
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": 10.0,
"ret_3d": -3.59,
"ret_5d": -1.23,
"roc10_accel": 5.05,
"checks": {
"roc_over_5": true,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.19,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": true,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 1.9,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": true,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": false,
"avg_vol_over_2m": true,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 41655466.54,
"avg_vol": 6085532
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.8,
"iv_rank": 27.0
}
}
}
}
Data:
{
"prior_day": {
"high": 7.0,
"low": 6.74,
"close": 6.85,
"date": "2026-08-28"
},
"woodie_pivots": {
"PP": 6.86,
"R1": 6.98,
"S1": 6.72,
"R2": 7.12,
"S2": 6.6
},
"swing": {
"high_20d": 7.58,
"low_20d": 5.88,
"high_60d": 7.58,
"low_60d": 4.45
},
"orb": {
"high": 7.0,
"low": 6.81,
"date": "2026-08-28"
},
"vwap": 6.82,
"volume_profile": {
"poc": 6.47,
"vah": 6.89,
"val": 5.92,
"sessions": 20
},
"premarket": {
"date": "2026-08-28",
"high": 7.01,
"low": 6.79,
"last": 6.98,
"volume": 4571,
"gap_pct": -0.14,
"path": "05:15 6.99 -> 05:25 6.79 -> 05:45 6.98 -> 07:00 7.01 -> 08:25 7.00 -> 08:50 7.00 -> 09:15 6.97 -> 09:25 6.98",
"bars": 8,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-07-27",
"o": 6.605,
"h": 6.795,
"l": 6.53,
"c": 6.66,
"v": 6027011.533464
},
{
"d": "2026-07-28",
"o": 6.66,
"h": 6.7272,
"l": 6.41,
"c": 6.69,
"v": 5383342.661161
},
{
"d": "2026-07-29",
"o": 6.64,
"h": 6.77,
"l": 6.39,
"c": 6.59,
"v": 6883276.253559
},
{
"d": "2026-07-30",
"o": 6.49,
"h": 6.75,
"l": 6.415,
"c": 6.7,
"v": 5372169.883748
},
{
"d": "2026-07-31",
"o": 6.68,
"h": 6.69,
"l": 6.295,
"c": 6.33,
"v": 4891203.732779
},
{
"d": "2026-08-03",
"o": 6.36,
"h": 6.42,
"l": 6.075,
"c": 6.16,
"v": 5569449.390813
},
{
"d": "2026-08-04",
"o": 6.26,
"h": 6.535,
"l": 6.21,
"c": 6.44,
"v": 4652427.553442
},
{
"d": "2026-08-05",
"o": 6.49,
"h": 6.57,
"l": 6.34,
"c": 6.37,
"v": 5497213.564081
},
{
"d": "2026-08-06",
"o": 6.06,
"h": 6.63,
"l": 6.01,
"c": 6.11,
"v": 8394940.507837
},
{
"d": "2026-08-07",
"o": 6.3,
"h": 6.635,
"l": 6.2063,
"c": 6.6,
"v": 5777358.512899
},
{
"d": "2026-08-10",
"o": 6.6,
"h": 6.62,
"l": 6.37,
"c": 6.6,
"v": 4838706.284853
},
{
"d": "2026-08-11",
"o": 6.6,
"h": 6.62,
"l": 6.37,
"c": 6.37,
"v": 4125009.774139
},
{
"d": "2026-08-12",
"o": 6.42,
"h": 6.475,
"l": 6.315,
"c": 6.42,
"v": 2592651.632054
},
{
"d": "2026-08-13",
"o": 6.47,
"h": 6.49,
"l": 6.075,
"c": 6.1,
"v": 5229724.904285
},
{
"d": "2026-08-14",
"o": 6.02,
"h": 6.28,
"l": 5.88,
"c": 6.22,
"v": 13327001.557427
},
{
"d": "2026-08-17",
"o": 6.13,
"h": 6.6,
"l": 6.13,
"c": 6.48,
"v": 5055139.63848
},
{
"d": "2026-08-18",
"o": 6.57,
"h": 6.96,
"l": 6.44,
"c": 6.96,
"v": 6993659.299307
},
{
"d": "2026-08-19",
"o": 7.16,
"h": 7.58,
"l": 7.02,
"c": 7.26,
"v": 11552379.094602
},
{
"d": "2026-08-20",
"o": 7.31,
"h": 7.31,
"l": 6.76,
"c": 6.83,
"v": 5312516.900576
},
{
"d": "2026-08-21",
"o": 6.98,
"h": 7.09,
"l": 6.88,
"c": 6.93,
"v": 6044564.822079
},
{
"d": "2026-08-24",
"o": 6.82,
"h": 6.97,
"l": 6.66,
"c": 6.76,
"v": 3015226.886387
},
{
"d": "2026-08-25",
"o": 6.93,
"h": 7.13,
"l": 6.855,
"c": 7.1,
"v": 4154798.340768
},
{
"d": "2026-08-26",
"o": 7.09,
"h": 7.12,
"l": 6.91,
"c": 6.96,
"v": 3441013.329176
},
{
"d": "2026-08-27",
"o": 6.91,
"h": 7.18,
"l": 6.88,
"c": 6.99,
"v": 3531344.944251
},
{
"d": "2026-08-28",
"o": 6.9,
"h": 6.9956,
"l": 6.735,
"c": 6.85,
"v": 1038415.850479
}
]
}
Data:
{
"estimates": [
{
"symbol": "NUVB",
"date": "2030-12-31",
"revenueLow": 654764141,
"revenueHigh": 937285777,
"revenueAvg": 779258500,
"ebitdaLow": 130952828,
"ebitdaHigh": 187457155,
"ebitdaAvg": 155851699,
"ebitLow": 130952828,
"ebitHigh": 187457155,
"ebitAvg": 155851699,
"netIncomeLow": 150185824,
"netIncomeHigh": 239526119,
"netIncomeAvg": 189555255,
"sgaExpenseLow": 1859951766,
"sgaExpenseHigh": 2662495129,
"sgaExpenseAvg": 2213595908,
"epsAvg": 0.555,
"epsHigh": 0.70131,
"epsLow": 0.43973,
"numAnalystsRevenue": 4,
"numAnalystsEps": 3
},
{
"symbol": "NUVB",
"date": "2029-12-31",
"revenueLow": 444765425,
"revenueHigh": 636675530,
"revenueAvg": 529331428,
"ebitdaLow": 88953084,
"ebitdaHigh": 127335105,
"ebitdaAvg": 105866285,
"ebitLow": 88953084,
"ebitHigh": 127335105,
"ebitAvg": 105866285,
"netIncomeLow": 12628417,
"netIncomeHigh": 20140601,
"netIncomeAvg": 15938693,
"sgaExpenseLow": 1263420193,
"sgaExpenseHigh": 1808568463,
"sgaExpenseAvg": 1503642094,
"epsAvg": 0.046667,
"epsHigh": 0.05896979,
"epsLow": 0.03697482,
"numAnalystsRevenue": 4,
"numAnalystsEps": 3
},
{
"symbol": "NUVB",
"date": "2028-12-31",
"revenueLow": 309577997,
"revenueHigh": 603999994,
"revenueAvg": 419278876,
"ebitdaLow": 61915599,
"ebitdaHigh": 120799998,
"ebitdaAvg": 83855775,
"ebitLow": 61915599,
"ebitHigh": 120799998,
"ebitAvg": 83855775,
"netIncomeLow": -109371674,
"netIncomeHigh": 140130857,
"netIncomeAvg": 3217000,
"sgaExpenseLow": 879400850,
"sgaExpenseHigh": 1715748901,
"sgaExpenseAvg": 1191021983,
"epsAvg": 0.005644,
"epsHigh": 0.41029,
"epsLow": -0.32023,
"numAnalystsRevenue": 9,
"numAnalystsEps": 9
},
{
"symbol": "NUVB",
"date": "2027-12-31",
"revenueLow": 270443511,
"revenueHigh": 297854980,
"revenueAvg": 282426616,
"ebitdaLow": 54088702,
"ebitdaHigh": 59570995,
"ebitdaAvg": 56485323,
"ebitLow": 54088702,
"ebitHigh": 59570995,
"ebitAvg": 56485323,
"netIncomeLow": -100354992,
"netIncomeHigh": -27018707,
"netIncomeAvg": -28528000,
"sgaExpenseLow": 768233711,
"sgaExpenseHigh": 846099933,
"sgaExpenseAvg": 802273445,
"epsAvg": -0.19212,
"epsHigh": -0.07910824,
"epsLow": -0.29383,
"numAnalystsRevenue": 9,
"numAnalystsEps": 6
}
],
"price_target": {
"symbol": "NUVB",
"targetHigh": 21,
"targetLow": 20,
"targetConsensus": 20.5,
"targetMedian": 20.5
},
"ratings": {
"symbol": "NUVB",
"rating": "C-",
"overallScore": 1,
"discountedCashFlowScore": 3,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "NUVB",
"date": "2026-08-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-07-27",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-07-23",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-07-07",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-05-05",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-05-05",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-05-05",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-04-16",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-04-02",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-03-27",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-03-03",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-03-03",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-02-10",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-01-21",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2026-01-12",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2025-12-11",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2025-12-01",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2025-11-20",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2025-11-04",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2025-11-04",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2025-10-13",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2025-09-19",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NUVB",
"date": "2025-09-08",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma",
"url": "https://www.prnewswire.com/news-releases/nuvation-bio-granted-fda-fast-track-designation-for-safusidenib-for-treatment-of-idh1-mutant-glioma-302855678.html",
"source": "PRNewsWire",
"date": "2026-08-20 08:00:00",
"summary": "Designation offers pathway to expedite regulatory review, pending positive data, and reinforces safusidenib's potential to address significant medical needs for patients with IDH1-mutant glioma Pivotal Phase 3 SIGMA study enrollment underway NEW YORK, Aug. 20, 2026 /PRNewswire/ -",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-granted-fda-fast-track-designation-for-safusidenib-20260820.jpg"
},
{
"title": "Wall Street Analysts Predict a 105.71% Upside in Nuvation Bio (NUVB): Here's What You Should Know",
"url": "https://www.zacks.com/stock/news/2976282/wall-street-analysts-predict-a-105-71-upside-in-nuvation-bio-nuvb-here-s-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|consensus_price_target-2976282",
"source": "Zacks Investment Research",
"date": "2026-08-18 10:56:06",
"summary": "The mean of analysts' price targets for Nuvation Bio (NUVB) points to a 105.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.",
"image": "https://images.financialmodelingprep.com/news/wall-street-analysts-predict-a-10571-upside-in-nuvation-20260818.jpg"
},
{
"title": "Critical Analysis: Pathfinder Cell Therapy (OTCMKTS:PFND) and Nuvation Bio (NYSE:NUVB)",
"url": "https://www.defenseworld.net/2026/08/16/critical-analysis-pathfinder-cell-therapy-otcmktspfnd-and-nuvation-bio-nysenuvb.html",
"source": "Defense World",
"date": "2026-08-16 03:46:10",
"summary": "Nuvation Bio (NYSE: NUVB - Get Free Report) and Pathfinder Cell Therapy (OTCMKTS:PFND - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analy",
"image": "https://images.financialmodelingprep.com/news/critical-analysis-pathfinder-cell-therapy-otcmktspfnd-and-nuvation-bio-20260816.jpg"
},
{
"title": "Nuvation Bio Q2 Earnings Call Highlights",
"url": "https://www.marketbeat.com/instant-alerts/nuvation-bio-q2-earnings-call-highlights-2026-08-08/",
"source": "MarketBeat",
"date": "2026-08-08 17:04:05",
"summary": "Nuvation Bio NYSE: NUVB reported second-quarter total revenue of $31.7 million, including $23.2 million in net U.S. product revenue from IBTROZI, as the company said use of the ROS1-targeted lung cancer therapy continued to shift toward first-line patients.",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-q2-earnings-call-highlights-20260808.jpg"
},
{
"title": "Nuvation Bio Inc. (NUVB) Q2 2026 Earnings Call Transcript",
"url": "https://seekingalpha.com/article/4931908-nuvation-bio-inc-nuvb-q2-2026-earnings-call-transcript",
"source": "Seeking Alpha",
"date": "2026-08-06 12:14:23",
"summary": "Nuvation Bio Inc. (NUVB) Q2 2026 Earnings Call Transcript",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-inc-nuvb-q2-2026-earnings-call-transcript-20260806.jpg"
},
{
"title": "Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates",
"url": "https://www.zacks.com/stock/news/2969886/nuvation-bio-inc-nuvb-reports-q2-loss-beats-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2969886",
"source": "Zacks Investment Research",
"date": "2026-08-06 10:51:23",
"summary": "Nuvation Bio Inc. (NUVB) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.17 per share a year ago.",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-inc-nuvb-reports-q2-loss-beats-revenue-20260806.jpg"
},
{
"title": "Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update",
"url": "https://www.prnewswire.com/news-releases/nuvation-bio-reports-second-quarter-2026-financial-results-and-provides-business-update-302844260.html",
"source": "PRNewsWire",
"date": "2026-08-06 07:30:00",
"summary": "Achieved $31.7 million in second quarter 2026 total revenue, including $23.2 million in net product revenue for IBTROZI \u00ae (taletrectinib) IBTROZI is the most prescribed ROS1 TKI in in both first-line and overall new patient starts in 2026 based on IQVIA claims from first five mon",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-reports-second-quarter-2026-financial-results-and-20260806.jpg"
},
{
"title": "Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI\u00ae (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses",
"url": "https://www.prnewswire.com/news-releases/nuvation-bio-to-present-new-subgroup-analyses-of-pivotal-data-for-ibtrozi-taletrectinib-in-advanced-ros1-positive-non-small-cell-lung-cancer-at-wclc-and-esmo-annual-congresses-302841746.html",
"source": "PRNewsWire",
"date": "2026-08-04 08:00:00",
"summary": "Analyses of long-term TRUST-I and TRUST-II data will examine consistency of efficacy across key patient subgroups NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatme",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-to-present-new-subgroup-analyses-of-pivotal-20260804.jpg"
},
{
"title": "4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates",
"url": "https://www.zacks.com/stock/news/2966652/4-biotech-stocks-likely-to-outpace-q2-earnings-estimates?cid=CS-STOCKNEWSAPI-FT-earnings_esp-2966652",
"source": "Zacks Investment Research",
"date": "2026-08-03 11:35:25",
"summary": "Medical sector earnings are off to a strong start, and four biotech companies are positioned to potentially beat estimates in upcoming quarterly results.",
"image": "https://images.financialmodelingprep.com/news/4-biotech-stocks-likely-to-outpace-q2-earnings-estimates-20260803.jpg"
},
{
"title": "Nuvation Bio Inc. (NUVB) Expected to Beat Earnings Estimates: Should You Buy?",
"url": "https://www.zacks.com/stock/news/2964571/nuvation-bio-inc-nuvb-expected-to-beat-earnings-estimates-should-you-buy?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2964571",
"source": "Zacks Investment Research",
"date": "2026-07-30 11:06:11",
"summary": "Nuvation Bio (NUVB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-inc-nuvb-expected-to-beat-earnings-estimates-20260730.jpg"
},
{
"title": "Wall Street Analysts See a 94.32% Upside in Nuvation Bio (NUVB): Can the Stock Really Move This High?",
"url": "https://www.zacks.com/stock/news/2963199/wall-street-analysts-see-a-94-32-upside-in-nuvation-bio-nuvb-can-the-stock-really-move-this-high?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|consensus_price_target-2963199",
"source": "Zacks Investment Research",
"date": "2026-07-29 10:56:13",
"summary": "The consensus price target hints at a 94.3% upside potential for Nuvation Bio (NUVB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term",
"image": "https://images.financialmodelingprep.com/news/wall-street-analysts-see-a-9432-upside-in-nuvation-20260729.jpg"
},
{
"title": "Nuvation Bio to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026",
"url": "https://www.prnewswire.com/news-releases/nuvation-bio-to-report-second-quarter-2026-financial-results-and-provide-business-update-on-august-6-2026-302830730.html",
"source": "PRNewsWire",
"date": "2026-07-22 16:05:00",
"summary": "NEW YORK, July 22, 2026 /PRNewswire/ -- Nuvation Bio Inc. (\"Nuvation Bio\") (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it will host a conference call and webcast on Thursday, August 6, 2026, at 8",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-to-report-second-quarter-2026-financial-results-20260722.jpg"
},
{
"title": "Nuvation Bio (NUVB) Soars 7.9%: Is Further Upside Left in the Stock?",
"url": "https://www.zacks.com/stock/news/2957322/nuvation-bio-nuvb-soars-7-9-is-further-upside-left-in-the-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|daily_price_change_5%-2957322",
"source": "Zacks Investment Research",
"date": "2026-07-21 11:10:25",
"summary": "Nuvation Bio (NUVB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-nuvb-soars-79-is-further-upside-left-20260721.jpg"
},
{
"title": "Nuvation Bio Announces Positive Updated Phase 2 Data and Expansion of Safusidenib Clinical Program with Two New Studies to Explore Broad Spectrum of IDH1-Mutant Glioma",
"url": "https://www.prnewswire.com/news-releases/nuvation-bio-announces-positive-updated-phase-2-data-and-expansion-of-safusidenib-clinical-program-with-two-new-studies-to-explore-broad-spectrum-of-idh1-mutant-glioma-302828874.html",
"source": "PRNewsWire",
"date": "2026-07-20 08:00:00",
"summary": "Updated data from Phase 2 study show confirmed objective response rate of 52% and 36-month progression-free survival rate of 79% with\u00a0nearly\u00a040\u00a0months\u00a0of follow-up New Phase 3 study to evaluate safusidenib in newly diagnosed grade 2 glioma patients outside the U.S. New Phase 2 st",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-announces-positive-updated-phase-2-data-and-20260720.jpg"
},
{
"title": "Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering",
"url": "https://www.prnewswire.com/news-releases/nuvation-bio-inc-announces-full-exercise-of-greenshoe-option-in-287-5-million-convertible-senior-notes-offering-302818744.html",
"source": "PRNewsWire",
"date": "2026-07-06 17:09:00",
"summary": "NEW YORK, July 6, 2026 /PRNewswire/ -- Nuvation Bio Inc. (\"Nuvation Bio\") (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the underwriters have exercised in full their over-allotment option (the",
"image": "https://images.financialmodelingprep.com/news/nuvation-bio-inc-announces-full-exercise-of-greenshoe-option-20260706.jpg"
},
{
"title": "Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?",
"url": "https://www.fool.com/coverage/filings/2026/06/29/nuvation-bio-stock-is-up-190-despite-recent-pressure-should-investors-care-about-this-usd753-000-insider-sale/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-06-29T23:19:05Z",
"summary": "Nuvation Bio's Chief People Officer Stacy Markel sold 125,000 shares worth $753,000 on June 23, 2026, reducing her direct holdings by 79.32%. However, the sale was executed under a pre-established trading plan adopted in December 2025, and Markel retains significant exposure thro",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F1a599f395be31e2f508c3aa7decb988f9ce983b7-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum",
"url": "https://www.fool.com/coverage/filings/2026/06/17/veteran-pharma-vc-insider-buys-25-000-nuvation-bio-shares-as-new-drug-gains-momentum/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-06-17T16:01:53Z",
"summary": "Robert Mashal, an oncology-trained director at Nuvation Bio, purchased 25,000 shares at $4.73 per share on June 9, 2026, bringing his total indirect holdings to 225,000 shares. The purchase comes as Nuvation's first FDA-approved cancer drug, Ibtrozi, continues gaining traction wi",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2Fffcb96c38b084cd623d7bbcf925cde38d84e836d-1536x1024.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Insider Sells 200K Shares of Biotech Company Nuvation Bio (NUVB)",
"url": "https://www.fool.com/coverage/filings/2026/04/13/insider-sells-200k-shares-of-biotech-company-nuvation-bio-nuvb/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-04-13T04:04:41Z",
"summary": "Kerry Wentworth, Chief Regulatory Officer of Nuvation Bio, sold 200,000 Class A shares for approximately $904,000 on April 6, 2026, reducing his direct holdings by 79%. However, he retains 53,000 shares and 700,000 stock options, suggesting the sale is a routine profit-taking exe",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F6f699693a3501babe6eb40aac5d3061bf74bda96-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "NUVB Investors Have Opportunity to Join Nuvation Bio Inc. Fraud Investigation with the Schall Law Firm",
"url": "https://www.benzinga.com/pressreleases/26/03/b51395993/nuvb-investors-have-opportunity-to-join-nuvation-bio-inc-fraud-investigation-with-the-schall-law-f?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-03-21T21:15:00Z",
"summary": "The Schall Law Firm is investigating Nuvation Bio Inc. for potential securities law violations following the company's Q4 2025 earnings report. The company revealed that 75% of treatment discontinuations for its IBTROZI oncology therapy occurred in later-line patient populations,",
"image": "https://cdn.benzinga.com/files/imagecache/bz2_opengraph_meta_image_400x300/sites/all/themes/bz2/images/bz-icon.png"
},
{
"title": "INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PayPal Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines \u2013 PYPL",
"url": "https://www.globenewswire.com/news-release/2026/03/10/3253284/1087/en/INVESTOR-ALERT-Pomerantz-Law-Firm-Reminds-Investors-with-Losses-on-their-Investment-in-PayPal-Holdings-Inc-of-Class-Action-Lawsuit-and-Upcoming-Deadlines-PYPL.html",
"source": "GlobeNewswire Inc.",
"date": "2026-03-10T19:52:00Z",
"summary": "Pomerantz Law Firm has filed class action lawsuits against PayPal Holdings and Snowflake Inc., with deadlines for investors to join. PayPal announced disappointing Q4 2025 earnings, CEO departure, and withdrawn 2027 guidance due to macroeconomic factors and operational issues. Th",
"image": "https://www.globenewswire.com/news-release/2026/03/10/3253284/1087/en/INVESTOR-ALERT-Pomerantz-Law-Firm-Reminds-Investors-with-Losses-on-their-Investment-in-PayPal-Holdings-Inc-of-Class-Action-Lawsuit-and-Upcoming-Deadlines-PYPL.html"
},
{
"title": "New Treatment Modalities Are Reaching Cancers That Resisted Everything Else",
"url": "https://www.benzinga.com/pressreleases/26/02/n50657415/new-treatment-modalities-are-reaching-cancers-that-resisted-everything-else?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-02-17T16:17:00Z",
"summary": "Several biotech companies are advancing novel cancer treatments through clinical development. Oncolytics Biotech received FDA Fast Track Designation for pelareorep in KRAS-mutant colorectal cancer, showing doubled survival benefits. Novocure gained FDA approval for Optune Pax for",
"image": "https://www.benzinga.com/next-assets/images/benzinga-schema-image-default.png"
},
{
"title": "Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan \u2014 Here's What to Know About the Stock",
"url": "https://www.fool.com/coverage/filings/2025/11/03/nuvation-bio-chief-scientist-sells-100-000-shares-under-trading-plan-here-s-what-to-know-about-the-stock/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2025-11-03T11:10:53Z",
"summary": "Gary Hattersley, chief scientific officer at Nuvation Bio, exercised and sold 100,000 shares under a pre-planned trading strategy, reducing his direct stock ownership to zero while retaining 298,935 stock options.",
"image": "https://cdn.content.foolcdn.com/images/1umn9qeh/production/ff082944a4120fa27e82bf8173c01cf6c264bcad-6735x3900.jpg?w=6735&h=3900"
}
]
Data:
[
{
"symbol": "NUVB",
"date": "2026-11-02",
"epsActual": null,
"epsEstimated": -0.12,
"revenueActual": null,
"revenueEstimated": 35765060,
"lastUpdated": "2026-08-28"
},
{
"symbol": "NUVB",
"date": "2026-08-06",
"epsActual": -0.15,
"epsEstimated": -0.14166,
"revenueActual": 31687000,
"revenueEstimated": 27027370,
"lastUpdated": "2026-08-28"
},
{
"symbol": "NUVB",
"date": "2026-05-04",
"epsActual": 0.01,
"epsEstimated": -0.02804,
"revenueActual": 83228000,
"revenueEstimated": 66221700,
"lastUpdated": "2026-08-04"
},
{
"symbol": "NUVB",
"date": "2026-03-02",
"epsActual": -0.11,
"epsEstimated": -0.11,
"revenueActual": 41865000,
"revenueEstimated": 37814760,
"lastUpdated": "2026-06-02"
},
{
"symbol": "NUVB",
"date": "2025-11-03",
"epsActual": -0.16,
"epsEstimated": -0.17,
"revenueActual": 13120000,
"revenueEstimated": 36821810,
"lastUpdated": "2026-02-03"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "NUVB",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "NUVB",
"periods": [
{
"file_period": "202604a",
"settlement_date": "20260409",
"quantity_fails": 372,
"price": 4.53
},
{
"file_period": "202604b",
"settlement_date": "20260424",
"quantity_fails": 1595,
"price": 5.04
},
{
"file_period": "202606a",
"settlement_date": "20260609",
"quantity_fails": 17234,
"price": 4.8
},
{
"file_period": "202606b",
"settlement_date": "20260629",
"quantity_fails": 1750332,
"price": 5.65
},
{
"file_period": "202607a",
"settlement_date": "20260714",
"quantity_fails": 87,
"price": 5.77
},
{
"file_period": "202607b",
"settlement_date": "20260728",
"quantity_fails": 24000,
"price": 6.66
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "NUVB",
"filingDate": "2026-08-21",
"transactionDate": "2026-08-19",
"reportingCik": "0001521111",
"companyCik": "0001811063",
"transactionType": "M-Exempt",
"securitiesOwned": 400000,
"reportingName": "Hattersley Gary",
"typeOfOwner": "officer: CHIEF SCIENTIFIC OFFICER",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 100000,
"price": 1.87,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1811063/000152111126000005/0001521111-26-000005-index.htm"
},
{
"symbol": "NUVB",
"filingDate": "2026-08-21",
"transactionDate": "2026-08-19",
"reportingCik": "0001521111",
"companyCik": "0001811063",
"transactionType": "M-Exempt",
"securitiesOwned": 100000,
"reportingName": "Hattersley Gary",
"typeOfOwner": "officer: CHIEF SCIENTIFIC OFFICER",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 100000,
"price": 1.87,
"securityName": "Class A Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1811063/000152111126000005/0001521111-26-000005-index.htm"
},
{
"symbol": "NUVB",
"filingDate": "2026-08-21",
"transactionDate": "2026-08-19",
"reportingCik": "0001521111",
"companyCik": "0001811063",
"transactionType": "S-Sale",
"securitiesOwned": 0,
"reportingName": "Hattersley Gary",
"typeOfOwner": "officer: CHIEF SCIENTIFIC OFFICER",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 100000,
"price": 7.0924,
"securityName": "Class A Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1811063/000152111126000005/0001521111-26-000005-index.htm"
},
{
"symbol": "NUVB",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-15",
"reportingCik": "0002039891",
"companyCik": "0001811063",
"transactionType": "M-Exempt",
"securitiesOwned": 662333,
"reportingName": "Sauvage Philippe",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 39999,
"price": 2.17,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1811063/000203989126000008/0002039891-26-000008-index.htm"
},
{
"symbol": "NUVB",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-15",
"reportingCik": "0002039891",
"companyCik": "0001811063",
"transactionType": "M-Exempt",
"securitiesOwned": 499999,
"reportingName": "Sauvage Philippe",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1,
"price": 1.97,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1811063/000203989126000008/0002039891-26-000008-index.htm"
},
{
"symbol": "NUVB",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-15",
"reportingCik": "0002039891",
"companyCik": "0001811063",
"transactionType": "M-Exempt",
"securitiesOwned": 54131,
"reportingName": "Sauvage Philippe",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1,
"price": 1.97,
"securityName": "Class A Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1811063/000203989126000008/0002039891-26-000008-index.htm"
},
{
"symbol": "NUVB",
"filingDate": "2026-07-17",
"transactionDate": "2026-07-15",
"reportingCik": "0002039891",
"companyCik": "0001811063",
"transactionType": "M-Exempt",
"securitiesOwned": 54130,
"reportingName": "Sauvage Philippe",
"typeOfOwner": "officer: Chief Financial Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 39999,
"price": 2.17,
"securityName": "Class A Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1811063/000203989126000008/0002039891-26-000008-index.htm"
},
{
"symbol": "NUVB",
"filingDate": "2026-06-24",
"transactionDate": "2026-06-23",
"reportingCik": "0001734780",
"companyCik": "0001811063",
"transactionType": "M-Exempt",
"securitiesOwned": 409620,
"reportingName": "Markel Stacy",
"typeOfOwner": "officer: CHIEF PEOPLE OFFICER",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 90380,
"price": 1.87,
"securityName": "Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/0001734780-26-000004-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "NUVB",
"executed_at": "2026-08-28T15:10:07.936000Z",
"size": 500.0,
"price": 6.835,
"premium": 3417.5,
"volume": 500.0,
"trade_code": " "
},
{
"ticker": "NUVB",
"executed_at": "2026-08-28T15:11:56.903000Z",
"size": 478.0,
"price": 6.835,
"premium": 3267.13,
"volume": 478.0,
"trade_code": " "
},
{
"ticker": "NUVB",
"executed_at": "2026-08-28T15:10:39.641000Z",
"size": 400.0,
"price": 6.845,
"premium": 2738.0,
"volume": 400.0,
"trade_code": " "
},
{
"ticker": "NUVB",
"executed_at": "2026-08-28T15:12:39.227000Z",
"size": 300.0,
"price": 6.845,
"premium": 2053.5,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "NUVB",
"executed_at": "2026-08-28T15:10:16.193000Z",
"size": 300.0,
"price": 6.835,
"premium": 2050.5,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "NUVB",
"executed_at": "2026-08-28T15:11:56.672000Z",
"size": 291.0,
"price": 6.839,
"premium": 1990.1490000000001,
"volume": 291.0,
"trade_code": " "
},
{
"ticker": "NUVB",
"executed_at": "2026-08-28T15:17:02.632000Z",
"size": 213.0,
"price": 6.845,
"premium": 1457.985,
"volume": 213.0,
"trade_code": " "
},
{
"ticker": "NUVB",
"executed_at": "2026-08-28T15:17:00.317000Z",
"size": 200.0,
"price": 6.845,
"premium": 1369.0,
"volume": 200.0,
"trade_code": " "
}
],
"ats": {
"symbol": "NUVB",
"date": "20260827",
"ats_volume": 0,
"total_volume": 1556889,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260827",
"ats_ratio": 0.0
},
{
"date": "20260826",
"ats_ratio": 0.0
},
{
"date": "20260825",
"ats_ratio": 0.0
},
{
"date": "20260824",
"ats_ratio": 0.0
},
{
"date": "20260821",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "NUVB",
"days": [
{
"date": "2026-08-28",
"close": 6.85,
"vwap": 6.82,
"volume": 1038485,
"vwap_discount_pct": -0.45
},
{
"date": "2026-08-27",
"close": 6.99,
"vwap": 7.02,
"volume": 3531344,
"vwap_discount_pct": 0.5
},
{
"date": "2026-08-26",
"close": 6.96,
"vwap": 7.0,
"volume": 3441013,
"vwap_discount_pct": 0.55
},
{
"date": "2026-08-25",
"close": 7.1,
"vwap": 7.01,
"volume": 4154798,
"vwap_discount_pct": -1.28
},
{
"date": "2026-08-24",
"close": 6.76,
"vwap": 6.78,
"volume": 3015226,
"vwap_discount_pct": 0.3
}
],
"avg_vwap_discount_pct": -0.08,
"signal": "Neutral"
},
"options_flow": [
{
"sector": "Healthcare",
"option_type": "call",
"size": 100,
"delta": "0.575086757444773",
"premium": "20000.00",
"nbbo_ask": "2.20",
"expiry": "2028-01-21",
"price": "2.00",
"strike": "10",
"nbbo_bid": "1.70",
"underlying_price": "6.8491",
"volume": 105,
"option_chain_id": "NUVB280121C00010000",
"executed_at": "2026-08-28T14:44:12.284000Z",
"underlying_symbol": "NUVB",
"open_interest": 1008,
"implied_volatility": "0.854481703524887"
},
{
"sector": "Healthcare",
"option_type": "call",
"size": 100,
"delta": "0.549396645131907",
"premium": "12400.00",
"nbbo_ask": "1.50",
"expiry": "2027-01-15",
"price": "1.24",
"strike": "7.5",
"nbbo_bid": "1.00",
"underlying_price": "6.8491",
"volume": 101,
"option_chain_id": "NUVB270115C00007500",
"executed_at": "2026-08-28T14:44:12.284000Z",
"underlying_symbol": "NUVB",
"open_interest": 815,
"implied_volatility": "0.859802456453886"
}
],
"net_premium": {
"ticker": "NUVB",
"net_call_premium": "11062.00",
"net_put_premium": "-564.00",
"call_premium": "46171.00",
"put_premium": "1264.00",
"bullish_premium": "29393.00",
"bearish_premium": "17767.00",
"put_call_ratio": "0.01622718052738336714",
"iv_rank": "26.6694",
"implied_move_perc": "0.184000",
"gex_ratio": "0.42854007793691816176",
"gex_net_change": "-8690.6549",
"gex_call": "176193.2897",
"gex_put": "-75505.8861",
"gex_net": 100687.4036,
"gex_call_delta": "779511.3049",
"gex_put_delta": "-226347.1011",
"gex_date": "2026-08-28"
},
"hot_chains": [
{
"underlying_symbol": "NUVB",
"expires": "2026-10-16",
"open_interest": 156,
"option_type": "call",
"delta": 0.434641444208862,
"ask_volume": 90,
"last_price": "0.55",
"implied_volatility": "0.80692568805129",
"gamma": 0.1949734265517282,
"avg_price": "0.5151282051282051282051282052",
"bid_volume": 100,
"nbbo_ask": "0.55",
"strike": "7.5",
"option_symbol": "NUVB261016C00007500",
"total_premium": "10045.00",
"iv": 0.803849575270837,
"volume": 195,
"nbbo_bid": "0.50"
},
{
"underlying_symbol": "NUVB",
"expires": "2028-01-21",
"open_interest": 1008,
"option_type": "call",
"delta": 0.588344481985302,
"ask_volume": 105,
"last_price": "2.00",
"implied_volatility": "0.854481703524887",
"gamma": 0.0506586791048646,
"avg_price": "2.0000000000000000000000000000",
"bid_volume": 0,
"nbbo_ask": "2.20",
"strike": "10",
"option_symbol": "NUVB280121C00010000",
"total_premium": "21000.00",
"iv": 0.948873319982346,
"volume": 105,
"nbbo_bid": "1.75"
},
{
"underlying_symbol": "NUVB",
"expires": "2027-01-15",
"open_interest": 815,
"option_type": "call",
"delta": 0.54342546108482,
"ask_volume": 1,
"last_price": "1.24",
"implied_volatility": "0.859802456453886",
"gamma": 0.1050480028025704,
"avg_price": "1.2406930693069306930693069307",
"bid_volume": 100,
"nbbo_ask": "1.50",
"strike": "7.5",
"option_symbol": "NUVB270115C00007500",
"total_premium": "12531.00",
"iv": 0.890421514986924,
"volume": 101,
"nbbo_bid": "1.00"
},
{
"underlying_symbol": "NUVB",
"expires": "2026-09-18",
"open_interest": 3647,
"option_type": "call",
"delta": 0.368981297172705,
"ask_volume": 90,
"last_price": "0.17",
"implied_volatility": "0.595763531378016",
"gamma": 0.263060512990817,
"avg_price": "0.2787912087912087912087912088",
"bid_volume": 1,
"nbbo_ask": "0.50",
"strike": "7.5",
"option_symbol": "NUVB260918C00007500",
"total_premium": "2537.00",
"iv": 0.869968579602734,
"volume": 91,
"nbbo_bid": "0.05"
},
{
"underlying_symbol": "NUVB",
"expires": "2026-12-18",
"open_interest": 22,
"option_type": "put",
"delta": -0.490654575256284,
"ask_volume": 0,
"last_price": "1.54",
"implied_volatility": "0.802663433234831",
"gamma": 0.1286355787297575,
"avg_price": "1.5233333333333333333333333333",
"bid_volume": 6,
"nbbo_ask": "1.80",
"strike": "7.5",
"option_symbol": "NUVB261218P00007500",
"total_premium": "914.00",
"iv": 0.817426896406016,
"volume": 6,
"nbbo_bid": "1.50"
},
{
"underlying_symbol": "NUVB",
"expires": "2027-01-15",
"open_interest": 2045,
"option_type": "put",
"delta": -0.490654564472409,
"ask_volume": 2,
"last_price": "1.75",
"implied_volatility": "0.833613728059407",
"gamma": 0.1286355705569749,
"avg_price": "1.75",
"bid_volume": 0,
"nbbo_ask": "1.95",
"strike": "7.5",
"option_symbol": "NUVB270115P00007500",
"total_premium": "350.00",
"iv": 0.731284385780714,
"volume": 2,
"nbbo_bid": "1.60"
},
{
"underlying_symbol": "NUVB",
"expires": "2027-01-15",
"open_interest": 1422,
"option_type": "call",
"delta": 0.294250737120563,
"ask_volume": 1,
"last_price": "0.58",
"implied_volatility": "0.825320902613046",
"gamma": 0.1039282820886251,
"avg_price": "0.58",
"bid_volume": 0,
"nbbo_ask": "0.70",
"strike": "10",
"option_symbol": "NUVB270115C00010000",
"total_premium": "58.00",
"iv": 0.78212444145641,
"volume": 1,
"nbbo_bid": "0.30"
},
{
"underlying_symbol": "NUVB",
"expires": "2026-09-18",
"open_interest": 2356,
"option_type": "put",
"delta": -0.056285644970859,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0782784573784978,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "5",
"option_symbol": "NUVB260918P00005000",
"total_premium": "0",
"iv": 0.878009833714513,
"volume": 0,
"nbbo_bid": null
}
],
"gamma_profile": {
"ticker": "NUVB",
"spot": 6.85,
"date": "2026-08-28",
"flip_point": 5.55,
"net_gex": 100687.4,
"call_walls": [
{
"strike": 7.5,
"gex": 127327.03
},
{
"strike": 10.0,
"gex": 23708.12
},
{
"strike": 5.0,
"gex": 10544.59
}
],
"put_walls": [
{
"strike": 7.5,
"gex": -33644.07
},
{
"strike": 5.0,
"gex": -33455.83
},
{
"strike": 10.0,
"gex": -6620.82
}
],
"by_strike": [
{
"strike": 2.5,
"call_gex": 3947.02,
"put_gex": -1475.2,
"net_gex": 2471.83
},
{
"strike": 5.0,
"call_gex": 10544.59,
"put_gex": -33455.83,
"net_gex": -22911.24
},
{
"strike": 7.5,
"call_gex": 127327.03,
"put_gex": -33644.07,
"net_gex": 93682.96
},
{
"strike": 10.0,
"call_gex": 23708.12,
"put_gex": -6620.82,
"net_gex": 17087.29
},
{
"strike": 12.5,
"call_gex": 5415.1,
"put_gex": -15.16,
"net_gex": 5399.94
},
{
"strike": 15.0,
"call_gex": 2752.14,
"put_gex": -294.8,
"net_gex": 2457.34
},
{
"strike": 17.5,
"call_gex": 2499.28,
"put_gex": 0.0,
"net_gex": 2499.28
}
]
},
"oi_changes": {
"net_call_oi_change": -444,
"net_put_oi_change": -3,
"top": [
{
"strike": "7.5",
"oi_change": -442,
"type": "call"
},
{
"strike": "5",
"oi_change": -4,
"type": "put"
},
{
"strike": "7.5",
"oi_change": -2,
"type": "call"
},
{
"strike": "7.5",
"oi_change": 1,
"type": "put"
},
{
"strike": "2.5",
"oi_change": 0,
"type": "call"
}
]
}
}
Data:
{
"vix": 15.45,
"sp500": 7677.28,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.47,
"hy_spread": 2.69,
"treasury": {
"date": "2026-08-26",
"month1": 3.8,
"month2": 3.8,
"month3": 3.85,
"month6": 3.94,
"year1": 4.02,
"year2": 4.19,
"year3": 4.29,
"year5": 4.37,
"year7": 4.51,
"year10": 4.66,
"year20": 5.17,
"year30": 5.18
},
"events": [
{
"title": "Fed Chairman Warsh Speaks",
"currency": "USD",
"date": "2026-08-28",
"time_utc": "14:00",
"impact": "High",
"forecast": null,
"previous": null,
"actual": null,
"minutes_until": -20
},
{
"title": "Prelim Benchmark Payrolls Revision",
"currency": "USD",
"date": "2026-08-28",
"time_utc": "14:00",
"impact": "High",
"forecast": null,
"previous": "-911K",
"actual": null,
"minutes_until": -20
}
]
}
Data:
{
"days": 105,
"patterns": [
{
"name": "VWAP Touch",
"count": 105,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 105,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 105,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 101,
"pct": 96
},
{
"name": "Woodie Pivot Touch",
"count": 99,
"pct": 94
},
{
"name": "PDH/PDL Touch",
"count": 92,
"pct": 88
},
{
"name": "Open Retracement",
"count": 78,
"pct": 74
},
{
"name": "Gap Fill",
"count": 73,
"pct": 70
},
{
"name": "Darvas Box",
"count": 34,
"pct": 32
},
{
"name": "High Vol Open",
"count": 31,
"pct": 30
},
{
"name": "Power Hour",
"count": 23,
"pct": 22
}
]
}